Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape.
about
Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes.Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy miceas a Model for Assessing the Function of RNA-Binding Proteins during Neurogenesis and Neurological Disease
P2860
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape.
description
2017 nî lūn-bûn
@nan
2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Spinal muscular atrophy: antis ...... egrated therapeutic landscape.
@en
Spinal muscular atrophy: antis ...... egrated therapeutic landscape.
@nl
type
label
Spinal muscular atrophy: antis ...... egrated therapeutic landscape.
@en
Spinal muscular atrophy: antis ...... egrated therapeutic landscape.
@nl
prefLabel
Spinal muscular atrophy: antis ...... egrated therapeutic landscape.
@en
Spinal muscular atrophy: antis ...... egrated therapeutic landscape.
@nl
P2093
P2860
P50
P356
P1476
Spinal muscular atrophy: antis ...... tegrated therapeutic landscape
@en
P2093
Kevin Talbot
Matthew J A Wood
Melissa Bowerman
P2860
P304
P356
10.1093/HMG/DDX215
P577
2017-10-01T00:00:00Z